Author: News Room

Washington, DC, Aug. 14, 2024 (GLOBE NEWSWIRE) — The United States Mint (Mint) is pleased to announce the selection of its 2023 American Liberty High Relief 24 Karat Gold Coin as the Coin of the Year winner in Krause Publication’s annual award program.  The announcement was made during the American Numismatic Association’s World’s Fair of Money in Chicago.   “I couldn’t be more thrilled to receive this prestigious award on behalf of the Mint,” said the Honorable Ventris C. Gibson, Director of the United States Mint.  “I want to extend my congratulations and appreciation to the Mint’s artists and designers,…

Dublin, Aug. 14, 2024 (GLOBE NEWSWIRE) — The “Green Methanol Market by Feedstock (Biomass, Green Hydrogen, CCS), Derivative(Formaldehyde, Dimethyl Ether & Methyl Tert-Butyl Ether, Gasoline, Methanol-to-Olefin, Solvents), Application (Chemical Feedstock, Fuel), and Region – Forecasts to 2030” report has been added to ResearchAndMarkets.com’s offering.The global Green Methanol market is projected to grow from USD 1.9 billion in 2024 to USD 11.1 billion by 2030, at a CAGR of 33.8% during the forecast period.This growth is propelled by stringent government regulations aimed at reducing carbon dioxide emissions and combating climate change. Green methanol, produced from renewable sources such as captured CO2…

Plano, TX , Aug. 14, 2024 (GLOBE NEWSWIRE) — The Law Office of Joel M. Vecchio, a trusted personal injury firm in Plano, is proud to announce the launch of its new website. It is designed to offer a user-friendly and informative experience for individuals seeking legal assistance for motor vehicle collisions and other types of personal injury cases. The new site provides detailed information about its legal services, making it easier for victims to get the legal support they need. The Law Office of Joel M. Vecchio has a proven track record in personal injury cases, with a strong…

SALT LAKE CITY, Aug. 14, 2024 (GLOBE NEWSWIRE) — omniQ Corporation (OTCQB: OMQS) (“omniQ” or the “Company”), a leading provider of Artificial Intelligence (AI)-based solutions, today reported revenues of approximately $19.1 million in the second quarter, marking an improvement from the previous quarter. FINANCIAL HIGHLIGHTS: Key Improvements Compared to 2023 Gross margin for the three months ended June 30, 2024, substantially increased to 26% compared to 19% in Q2 2023Gross margin for the six months ended June 30, 2024, increased to 27% compared to 20% in the same period of 2023.Gross profit for the three months ended June 30, 2024,…

VANCOUVER, Wash., Aug. 14, 2024 (GLOBE NEWSWIRE) — Cyber Acoustics, the leading manufacturer of edtech for all classroom environments, today announced the AC-6014 USB-C Headset, further expanding its line of technology solutions for all K-12 and virtual classrooms. The AC-6014 rounds out Cyber Acoustics’ line of USB-C offerings that includes the recently announced AC-4014 headset and the AC-5014 headset, both of which include microphones, as well as the ACM-6005C USB-C headphones that do not have a mic. “As schools across the country head back to school, we are seeing an increase in requests for USB-C offerings as more schools adopt…

Quadient (Euronext Paris: QDT), a global automation platform powering secure and sustainable business connections, announced today it has been named a Major Player for the first time in two IDC MarketScape reports – IDC MarketScape: Worldwide Accounts Payable Automation Software for Midmarket 2024 Vendor Assessment (doc # US52378624, July 2024) and IDC MarketScape: Worldwide Accounts Payable Automation Software for Small Businesses 2024 Vendor Assessment (doc # US52378824, July 2024). IDC MarketScape is a premier vendor assessment tool, providing in-depth quantitative and qualitative technology market assessments of information and communication technology (ICT) vendors for a wide range of technology markets. The…

REDWOOD CITY, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced it has appointed Dr. Nicolas Roelofs to serve on its Board of Directors. “Nick is a fantastic addition to our board, bringing over 35 years of broad operational and advisory experience with leading healthcare, life science tools, and diagnostics companies,” said Omid Farokhzad, Chair and CEO of Seer. “His extensive experience and insights will be valuable as we advance our mission of opening up a new gateway to the proteome.” “I’m excited to work…

Maintained Cost-Efficient Operating Profile New Machine-Automated Pricing System Enhances Portfolio Growth Capabilities in Support of Multibillion Dollar Liquidity and Primary Capital Product Launch DALLAS, Aug. 14, 2024 (GLOBE NEWSWIRE) — Beneficient (NASDAQ: BENF) (“Ben” or the “Company”), a technology-enabled financial services holding company that provides liquidity and related trust and custody services to holders of alternative assets, today reported its financial results for the fiscal 2025 first quarter, which ended June 30, 2024. Commenting on the fiscal 2025 first quarter results, Beneficient management said: “Our financial results improved on a sequential basis resulting in our first profitable quarter as a public…

BALI, Indonesia, Aug. 14, 2024 (GLOBE NEWSWIRE) — Rivalz Network, aims to transform the AI landscape by introducing the first AI Intel Layer, has raised $9 million in recent funding rounds. This funding marks a pivotal moment for Rivalz as it continues to innovate in AI data and decentralized infrastructure. In addition to its leading investors, Rivalz has garnered support from a diverse group of backers, including Zee Prime, Caballeros, Formless Capital, Dweb3, Mask.io, BitsCrunch, SL2, Momentum6, 4RC, Stakewithus, NewTribe, Autonomy Capital, Optic, Emoote, BlockBuilders, OIG, The Rollup, IBC, DWF Labs, GSR, Rana, CFG Labs, Basics Capital, Blocktheory, Pragma, X21,…

Positive data from the Phase 2a clinical trial (CLEAR MIND ) evaluating Lomecel-B™ in Alzheimer’s disease presented in Featured Research Oral Presentation at Alzheimer’s Association International Conference® (AAIC)U.S. FDA granted Lomecel-B™ both Regenerative Medicine Advanced Therapy (RMAT) designation and Fast Track designation for the treatment of mild Alzheimer’s diseasePhase 2b clinical trial (ELPIS II) evaluating Lomecel-B™ in rare pediatric disease HLHS has achieved 70% enrollment with completion of enrollment targeted for the end of 2024Strengthened Board of Directors with election of 3 experienced industry veterans at Annual MeetingFocused expenditure management reduced first half Total Operating Expenses 22% year-over-yearFinancing transaction and warrant exercises…